Inovio Pharma (INO) Misses Q4 EPS by 65c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.17 +1.74%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.65). Revenue for the quarter came in at $120 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber sells part of its Aurora stake in block trade - Bloomberg
- Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
